Mixed Vector Immunization With Recombinant Adenovirus and MVA Can Improve Vaccine Efficacy While Decreasing Antivector Immunity-Reference-Cited by-同舟云学术

Mixed Vector Immunization With Recombinant Adenovirus and MVA Can Improve Vaccine Efficacy While Decreasing Antivector Immunity

Published:2012-08 Issue:8 Volume:20 Page:1633-1647
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Reyes-Sandoval Arturo,Rollier Christine S,Milicic Anita,Bauza Karolis,Cottingham Matthew G,Tang Choon-Kit,Dicks Matthew D,Wang Dong,Longley Rhea J,Wyllie David H,Hill Adrian VS

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference49 articles.

1. Viral vectors as vaccine platforms: deployment in sight;Rollier;Curr Opin Immunol,2011

2. Effect of preexisting immunity to adenovirus human serotype 5 antigens on the immune responses of nonhuman primates to vaccine regimens based on human- or chimpanzee-derived adenovirus vectors;McCoy;J Virol,2007

3. Protective T cell immunity against malaria liver stage after vaccination with live sporozoites under chloroquine treatment;Belnoue;J Immunol,2004

4. Enhanced CD8+ T cell immune responses and protection elicited against Plasmodium berghei malaria by prime boost immunization regimens using a novel attenuated fowlpox virus;Anderson;J Immunol,2004

5. Immune responses against a liver-stage malaria antigen induced by simian adenoviral vector AdCh63 and MVA prime-boost immunisation in non-human primates;Capone;Vaccine,2010

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ChAdOx1-vectored Lassa fever vaccine elicits a robust cellular and humoral immune response and protects guinea pigs against lethal Lassa virus challenge;npj Vaccines;2021-03-02

2. The Role of Adjuvants in the Application of Viral Vector Vaccines;Viral Vectors in Veterinary Vaccine Development;2020-12-01

3. Vaccine Nanocarriers;Biomedical Engineering;2018

4. Adjuvanting a viral vectored vaccine against pre-erythrocytic malaria;Scientific Reports;2017-08-04

5. Rational development of a protective P. vivax vaccine evaluated with transgenic rodent parasite challenge models;Scientific Reports;2017-04-18